The goal is not to import “fail fast” wholesale into medicine. Nor is it to preserve a system so risk-averse that it limits ...

In Precision Oncology 3.0 sophisticated algorithms analyse panomic data to hypothesize the molecular pathways that drive an individual patient's tumour, and hypothesize personalized treatments, using ...

In 2015, ASCO launched CancerLinQ (CLQ) in response to the Institute of Medicine’s call to medical societies to develop and implement rapid learning health systems. The goal of such systems is to ...

To inform the evolving implementation of CancerLinQ and other rapid-learning systems for oncology care, we sought to evaluate perspectives of patients with cancer regarding ethical issues. Using the ...

In many fields of business, someone else can enter right away and make just as much money and impact as those with years of experience. Your unique advantage is how quickly you can learn and evolve.

In late July, the Food and Drug Administration (FDA) approved selective use of Praluent, the first of a new class of cholesterol-lowering drugs (PCSK9 inhibitors). A similar drug, Repatha, is expected ...

A new study has focused on language acquisition in the brain. Even short repetitive exposure to novel words induced a rapid neural response increase that is suggested to manifest memory-trace ...